Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,851Revenue (TTM) $M4,084Net Margin (%)-82.9Altman Z-Score-1.0
Enterprise Value $M10,484EPS (TTM) $-15.2Operating Margin %-84.4Piotroski F-Score4
P/E(ttm)--Beneish M-Score-4.3Pre-tax Margin (%)-95.3Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio0.9Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %--Current Ratio1.1Lower Leverage y-yN
Price/Free Cash Flow4.8y-y EBITDA Growth Rate %--ROA % (ttm)-20.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-73.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M223ROIC % (ttm)-25.9Gross Margin Increase y-yY

Gurus Latest Trades with ENDP

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

ENDP is held by these investors:

ENDP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Campanelli PaulPresident, CEO 2017-03-16Buy2,300$10.7220.15view
Hutson Nancy JDirector 2017-03-09Sell5,325$10.8219.04view
KIMMEL ROGER HDirector 2016-11-15Sell14,000$17.38-25.89view
HIGGINS ARTHUR JDirector 2016-05-11Buy5,000$13.8-6.67view
KIMMEL ROGER HDirector 2016-05-10Buy7,000$15.53-17.06view
HIGGINS ARTHUR JDirector 2016-05-10Buy11,000$15.42-16.47view
Campanelli PaulGroup President, Generics 2016-05-10Buy13,000$15.53-17.06view
INGRAM DOUGLAS SDirector 2016-05-05Sell4,513$26.59-51.56view
Spengler WilliamDirector 2016-03-17Buy1,000$29.2-55.89view
Spengler WilliamDirector 2016-03-16Buy1,000$35.24-63.45view

Quarterly/Annual Reports about ENDP:

News about ENDP:

Articles On GuruFocus.com
Francis Chou Buys Pharmaceutical Stocks, Including Valeant May 17 2017 
Endo to Present at UBS Global Healthcare Conference May 01 2017 
Weitz Value Fund Comments on Endo International Apr 27 2017 
Endo to Announce First-Quarter 2017 Financial Results Apr 25 2017 
Endo International plc Announces Pricing of Private Offering of Senior Secured Notes Apr 12 2017 
Endo International plc Announces Proposed Private Offering of Senior Secured Notes Apr 10 2017 
Endo International plc Announces Plan to Refinance Existing Credit Agreement Apr 05 2017 
Aytu BioScience May Lead the Way in Low T Feb 28 2017 
Weitz Funds Comments on Endo International Jan 26 2017 
4 Stocks Reach Their 3-Year Lows Jan 21 2017 

More From Other Websites
Valeant Pharmaceuticals: Intrigued…Really? May 19 2017
BDSI CEO on Belbuca revenue potential: We're on an upward trend May 16 2017
New York county sues Purdue, J&J over opioid marketing May 15 2017
These Stocks Show Change of Direction May 15 2017
Edited Transcript of ENDP earnings conference call or presentation 9-May-17 12:30pm GMT May 13 2017
Today's Research Reports on Stocks to Watch: Endo International and Valeant Pharmaceuticals May 10 2017
Endo (ENDP) Beats on Q1 Earnings, Reaffirms '17 Guidance May 09 2017
Here's What's Behind Endo International plc's Rally Today May 09 2017
Endo (ENDP) Q1 Earnings Beat Estimates, Revenues in Line May 09 2017
Investor Network: Endo International Plc to Host Earnings Call May 09 2017
Endo reports 1Q loss May 09 2017
Endo profit beats on strong sales of generic drugs May 09 2017
Endo posts 7.7 percent rise in quarterly revenue May 09 2017
Endo Reports First-Quarter 2017 Financial Results May 09 2017
4 Drug Stocks Poised to Beat this Earnings Season May 08 2017
[$$] Suits Dog Guggenheim Chief May 06 2017
Generic Drug Industry Headwinds Lead to Moat Downgrades May 05 2017
Is Endo (ENDP) Poised for a Beat This Earnings Season? May 04 2017
Generics Drop Across Board as DOJ Inquiry Expands May 03 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat